ARCHIVES

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

Justice Department Clears SWOG Study Of Breast Cancer Treatment Costs

November 17, 1995

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975

Fox Chase, UCLA, U. Washington Win Neutron Contracts

October 5, 1979

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005